#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Asthma Dermatitis atopic Dementia Alzheimer's type Type 2 diabetes mellitus Breast cancer metastatic Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Myxoid liposarcoma Hydrocephalus Glomerulonephritis chronic Retinoblastoma Oropharyngeal cancer recurrent Glomerulonephritis membranoproliferative Giant cell tumour of tendon sheath Leiomyosarcoma metastatic Netherton's syndrome Nasopharyngeal cancer Von Hippel-Lindau disease Pleural mesothelioma Primary immunodeficiency syndrome Chemical burn Richter's syndrome More trials…

    Learn about Rare Diseases

    Mantle cell lymphoma – Treatment Isodicentric chromosome 15 syndrome – Treatment Medulloblastoma recurrent – Diagnostics Acute respiratory distress syndrome – Life with Disease Medulloblastoma recurrent – Life with Disease Ewing’s sarcoma – Basic Information Adrenogenital syndrome – Diagnostics Hereditary hypophosphataemic rickets – Diagnostics Pulmonary fibrosis – Trials in Disease Extranodal marginal zone B-cell lymphoma (MALT type) – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    [18F]CPFPX Etanercept Durvalumab Sar441566 Ramucirumab Mebufotenin Loratadine Ucart20X22 Glutathione INSULIN DEGLUDEC Azd5462 ZINC GLUCONATE IPN01195 Alxn2220 Progesterone Ph. Eur. Enmetazobactam Glyceryl Trinitrate Anhydrous Cholestyramine Glycine Anhydrous Docetaxel More therapies…

    Learn about Your Condition

    Biliary cancer metastatic Congenital aplastic anaemia Cough Juvenile spondyloarthritis Blood disorder T-cell lymphoma Adrenogenital syndrome Oxygen saturation Acoustic neuroma HER2 protein overexpression Thrombolysis Paedophilia Small fibre neuropathy Haemofiltration Foot deformity More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Azienda Ospedaliera di Padova

Azienda Ospedaliera di Padova

Via Nicolo' Giustiniani 2, Padua, 35128, Italy

Want to learn more about this study or check if you can participate? Contact us.

  • Study on the Safety of Salbutamol Inhalers with Propellants HFA-152a and HFA-134a for Adults with Asthma

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Salbutamol Sulfate
    France Greece Italy Poland Spain

  • Study on the Effectiveness and Safety of BIIB122 for Patients with Parkinson’s Disease

    Not recruiting

    2 1
    Investigated Diseases:
    • Parkinson’s disease
    Investigated Drugs:
    • N2-(3-(2-(2H-1,2,3-Triazol-2-Yl)Propan-2-Yl)-1-Cyclopropyl-1H-Pyrazol-5-Yl)-N4-Ethyl-5-(Trifluoromethyl)Pyrimidine-2,4-Diamine
    Austria France Germany Italy The Netherlands Poland +1

  • Study on Ianalumab for Patients with Systemic Lupus Erythematosus

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Systemic lupus erythematosus
    Investigated Drugs:
    • Emtricitabine
    • Entecavir
    • Ianalumab
    France Germany Italy Romania

  • Study on Vedolizumab for Children with Moderate to Severe Ulcerative Colitis

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Vedolizumab
    • Prednisone
    Belgium Croatia Greece Hungary Italy Poland

  • Study on the Long-Term Safety of Tavapadon for Patients with Parkinson’s Disease

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Parkinson’s disease
    Investigated Drugs:
    • Tavapadon
    Bulgaria Czechia France Germany Hungary Italy +2

  • Study Comparing Depemokimab, Mepolizumab, and Benralizumab for Adults and Adolescents with Severe Eosinophilic Asthma

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Asthma
    Investigated Drugs:
    • Benralizumab
    • Depemokimab
    • Mepolizumab
    Austria Finland France Germany Ireland Italy +6

  • Study on Tezepelumab for Symptom Relief in Patients Aged 12-80 with Eosinophilic Esophagitis

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Tezepelumab
    Austria Belgium Czechia Denmark Finland Germany +7

  • Study Comparing Daratumumab with Drug Combination for Young Patients with Newly Diagnosed Multiple Myeloma Eligible for Stem Cell Transplantation

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Plasma cell myeloma
    Investigated Drugs:
    • Ixazomib Citrate
    • Thalidomide
    • Bortezomib
    Czechia Greece Italy

  • Study on the Effectiveness of Decitabine and Tetrahydrouridine in Patients with Sickle Cell Disease Not Eligible for Hydroxyurea Treatment

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Sickle cell disease
    Investigated Drugs:
    • Decitabine
    • Hydroxycarbamide
    • Tetrahydrouridine
    France Greece Italy Spain

  • Study Comparing Talquetamab, Daratumumab, and Pomalidomide with Drug Combination for Patients with Relapsed or Refractory Multiple Myeloma

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Talquetamab
    • Daratumumab
    • Dexamethasone
    Belgium Czechia France Germany Greece Italy +3
Previous Page
1 … 33 34 35 36 37 … 41
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!